The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared ...

Patients with chronic obstructive pulmonary disease (COPD) face a significant cardiovascular burden both before and after diagnosis. Analyses presented at the European Respiratory Society (ERS) ...

Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in ...

A new study published in The American Journal of Medicine found tirzepatide, which is prescribed for diabetes and weight ...

Congress demonstrated that just under 50% of people assessed through the FRONTIER Hull Programme were diagnosed with chronic obstructive pulmonary disease (COPD) following a previous assessment via ...

The presentations will be available on Connect’s website under the publications and presentations section.

The Bronchiectasis and NTM Association announced today that two abstracts using Bronchiectasis and NTM Research Registry data were presented at the European Respiratory Society Congress, held ...

“When we blocked chitinase-like proteins in mice, we were able to reverse some of the damage,” said Dr. Tara Sutherland, lead ...

That observation encapsulates why chronic disease management as we practise it today is reactive rather than predictive.

About Kaia Health Kaia Health is a global leader in digital therapeutics, providing evidence-based programs for chronic disease management. Its clinically validated Kaia Breathe solution brings ...

M Indians suffer from asthma—13% of global cases. Mortality is far higher than average due to late diagnosis, outdated care, ...